The present invention relates to a pharmaceutical composition comprising a therapeutically effective amount of a compound of formula (I), or a pharmaceutically acceptable salt thereof, one or more surfactants with lubricant properties, one or more dry binders with disintegrant properties, one or more fillers and one or more disintegrants.COMPOSICION FARMACEUTICA QUE COMPRENDE EL ACIDO (4-{4-[5-(6-TRIFLUORO-METIL-PIRIDIN-3-IL-AMINO)-PIRIDIN-2-IL]-FENIL}-CICLOHEXIL)-ACETICO O SU SAL SODICA, TENSOACTIVOS, AGLUTINANTES SECOS CON PROPIEDADES DESINTEGRANTES, RELLENOS Y DESINTEGRANTES; PROCESO DE PREPARACION; Y USO EN UN TRASTORNO ASOCIADO A DGAT1.